4Filed Apr 9, 8:00 PM ET

SOPHiA GENETICS (SOPH) CPO Manuela Valente Sells Shares

$SOPH · SOPHiA GENETICS SA

Research Summary

AI-generated summary of this SEC filing

Updated

SOPHiA GENETICS (SOPH) CPO Manuela Valente Sells Shares

What Happened
Manuela Valente, Chief People Officer of SOPHiA GENETICS (SOPH), sold 3,824 shares in an open-market transaction on April 8, 2026. The weighted-average sale price was $4.85 per share (range $4.78–$4.94), for total proceeds of approximately $18,543. This was a sale (not a purchase) and was executed to satisfy tax withholding obligations related to RSU vesting.

Key Details

  • Transaction date: April 8, 2026; Form filed April 10, 2026 (appears timely).
  • Shares sold: 3,824; weighted-average price reported: $4.85; price range: $4.78–$4.94.
  • Total proceeds: ~$18,543.
  • Reason/footnotes: Sales effected to satisfy tax withholding for restricted stock units that vested on April 2 and 3, 2026; executed pursuant to a pre-established Rule 10b5-1 trading plan (non-discretionary).
  • Footnote also notes the filer can provide breakdown of how many shares sold at each price within the stated range upon written request.
  • Shares owned after the transaction: not reported in this filing.

Context
These transactions were tax-withholding related and part of a pre-established 10b5-1 plan, which insiders commonly use to sell shares tied to compensation events; such sales are generally considered routine and do not necessarily indicate a change in the insider’s view of the company. Purchases (not present here) tend to carry more informational weight for investors.